Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
School of Psychology, Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Br J Clin Pharmacol. 2019 Nov;85(11):2464-2478. doi: 10.1111/bcp.14075. Epub 2019 Sep 6.
The aim of this systematic review and meta-analysis was to synthesise the evidence relating to medication non-adherence and its association with health outcomes in people aged ≥50 years.
Seven databases were searched up to February 2019 for observational studies that measured medication (non-)adherence as a predictor of the following health outcomes in adults aged ≥50 years: healthcare utilisation (hospitalisation, emergency department visits, outpatient visits and general practitioner visits), mortality, adverse clinical events and quality of life. Screening and quality assessment using validated criteria were completed by 2 reviewers independently. Random effects models were used to generate pooled estimates of association using adjusted study results. The full methodological approach was published on PROSPERO (ID: CRD42017077264).
Sixty-six studies were identified for qualitative synthesis, with 11 of these studies eligible for meta-analyses. A meta-analysis including 3 studies measuring medication non-adherence in adults aged ≥55 years showed a significant association with all-cause hospitalisation (adjusted odds ratio 1.17, 95% confidence interval [CI] 1.12, 1.21). A meta-analysis including 2 studies showed that medication non-adherence was not significantly associated with an emergency department visit (adjusted odds ratio 1.05, 95% CI 0.90, 1.22). Good adherence was associated with a 21% reduction in long-term mortality risk in comparison to medication non-adherence (adjusted hazard ratio 0.79, 95% CI 0.63, 0.98).
Medication non-adherence may be significantly associated with all-cause hospitalisation and mortality in older people. Medication adherence should be monitored and addressed in this cohort to minimise hospitalisation, improve clinical outcomes and reduce healthcare costs.
本系统评价和荟萃分析的目的是综合与年龄≥50 岁人群药物不依从及其与健康结局的关系相关的证据。
截至 2019 年 2 月,我们在 7 个数据库中搜索了测量≥50 岁成年人药物(不)依从性作为以下健康结局预测指标的观察性研究:医疗保健利用(住院、急诊就诊、门诊就诊和全科医生就诊)、死亡率、不良临床事件和生活质量。两名审查员使用经过验证的标准进行了筛选和质量评估。使用调整后的研究结果,使用随机效应模型生成关联的汇总估计值。完整的方法学方法已在 PROSPERO 上发表(ID:CRD42017077264)。
定性综合分析确定了 66 项研究,其中 11 项研究符合荟萃分析的条件。包括 3 项研究的荟萃分析表明,≥55 岁成年人的药物不依从与全因住院显著相关(调整后的优势比 1.17,95%置信区间[CI] 1.12,1.21)。包括 2 项研究的荟萃分析表明,药物不依从与急诊科就诊无显著相关性(调整后的优势比 1.05,95%CI 0.90,1.22)。与药物不依从相比,良好依从性与长期死亡率风险降低 21%相关(调整后的危害比 0.79,95%CI 0.63,0.98)。
药物不依从可能与老年人的全因住院和死亡率显著相关。在该队列中应监测和解决药物依从性问题,以尽量减少住院、改善临床结局并降低医疗保健成本。